TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2010

Immunologic escape after prolonged progression-free survival with epidermal growth factor receptor variant III peptide vaccination in patients with newly diagnosed glioblastoma.

John H Sampson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.